Essential gene and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections
CA 2385822 A1 · Owner: Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. · Inventors: Gibbs, Carol P.; Fuchs, Thilo M.; Hueck, Christoph J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to methods for preparing therapeutic preventative , and/or diagnostic agents for treating microbial infections and to methods for identifying and characterising essential genes from <i>Helicobacter pylori</i>. The invention also relates to the identified nucleic acids which code for the essential gene products and to the polypeptides which are coded therefrom.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 31, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 31, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 31, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.